Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Plos One|July 26, 2021
Predicting the efficacy of COVID-19 convalescent plasma donor units with the Lumit Dx anti-receptor binding domain assaySanath Kumar Janaka, Natasha M Clark, David T Evans, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
Ex vivo evaluation of anti-EpCAM immunocytokine huKS-IL2 in ovarian cancerJoseph P Connor, Mildred Felder, Jacquelyn Hank, et al.
Transfusion|August 20, 2022
Blood products and liver transplantation: A strategy to balance optimal preparation with effective blood stewardshipChristopher J Little, Glen E Leverson, Laura L Hammel, et al.
Journal of Cancer|May 26, 2011
HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer TherapyXinran Xiang, Mingqian Feng, Mildred Felder, et al.
Gynecologic Oncology|November 9, 2011
Quality of life in cervical cancer survivors: patient and provider perspectives on common complications of cervical cancer and treatmentM Heather Einstein, Joanne K Rash, Richard J Chappell, et al.
Archives of Gynecology and Obstetrics|May 10, 2012
Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: long-term follow-up of a prospective trialDavid B Engle, Joseph P Connor, Peter C Morris, et al.
Plos One|March 8, 2022
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infectionNatasha M Clark, Sanath Kumar Janaka, William Hartman, et al.
Immunology|July 10, 2007
Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125)Jennifer A Belisle, Jennifer A A Gubbels, Cara A Raphael, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infectionNatasha M Clark, Sanath Kumar Janaka, William Hartman, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Donor Anti-Spike Immunity is Related to Recipient Recovery and Can Predict the Efficacy of Convalescent Plasma UnitsSanath Kumar Janaka, William Hartman, Huihui Mou, et al.
Pageof 5